Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a 503 error message with a 'Home' button and a footer revision note (Revision: v3.6.5), indicating the study record content is unavailable rather than updated. This aligns with an error page state rather than changes to the study data.SummaryDifference20%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays revision v3.6.4, replacing the previous v3.6.3. This represents a minor template update rather than any content change.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision label was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a minor update to the page version.SummaryDifference0.0%

- Check54 days agoChange Detected- The page footer shows Revision: v3.6.2, indicating an updated template/version is in use. The underlying study information and UI content remain the same, with no changes to study details or data.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page gains a recruitment status note stating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated revision label. It also standardizes the Intervention/Treatment label by removing the space around the slash.SummaryDifference0.4%

- Check75 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, replacing the previous revision tag. This reflects a new page version for internal tracking.SummaryDifference0.1%

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.